Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesca Prignano

Showing results (41-50 of 194) with videos related to

Pageof 20
Sort By:
International Journal of Dermatology|July 26, 2011
Etanercept therapy in a hepatitis B virus (HBV)-positive psoriatic patient developing a monoclonal gammopathy of undetermined significanceFrancesca Prignano, Federica Ricceri, Leonardo Pescitelli, et al.
Current Pharmaceutical Biotechnology|June 12, 2020
Novel Therapeutic Approaches and Targets for the Treatment of Atopic DermatitisLeonardo Pescitelli, Elia Rosi, Federica Ricceri, et al.
Transplantation|October 18, 2022
Psoriasis Flare in a Liver Transplant Patient: A Case Report of a Successful Treatment With ApremilastElia Rosi, Maria Thais Fastame, Antonella Di Cesare, et al.
Journal of Cutaneous Pathology|March 27, 2007
Fibrosis in regressing melanoma versus nonfibrosis in halo nevus upon melanocyte disappearance: could it be related to a different cytokine microenvironment?Silvia Moretti, Adelina Spallanzani, Cinzia Pinzi, et al.
Pediatric Dermatology|February 13, 2016
A Pediatric Case of Sclerodermatous Graft-Versus-Host Disease Responsive to Ultraviolet A1 PhototherapyLinda Lazzeri, Lara Tripo, Leonardo Pescitelli, et al.
Expert Opinion on Biological Therapy|August 23, 2022
Targeting IL-17A for the treatment of pustular psoriasis: a comprehensive reviewElia Rosi, Maria Thais Fastame, Antonella Di Cesare, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|June 22, 2026
Concomitant HS and PsO: Disease severity and inflammatory phenotypes during biologic therapyElisabetta Magnaterra, Elia Rosi, Antonella Di Cesare, et al.
International Journal of Dermatology|November 2, 2011
Why is Kikuchi-Fujimoto disease misleading?Francesca Prignano, Angelo Massimiliano D'Erme, Fabio Zanieri, et al.
JAAD Case Reports|February 12, 2019
Comment on "Oral lichenoid reaction in a psoriatic patient treated with secukinumab: A drug-related rather than a class-related adverse event?"Antonella Di Cesare, Roberto Maglie, Leonardo Pescitelli, et al.
International Journal of Dermatology|January 20, 2018
Cutaneous hyperpigmentation induced by apremilastAntonella Di Cesare, Leonardo Pescitelli, Federica Ricceri, et al.
Pageof 20

Showing results (41-50 of 194) with videos related to

Sort By:
Pageof 20
International Journal of Dermatology|July 26, 2011
Etanercept therapy in a hepatitis B virus (HBV)-positive psoriatic patient developing a monoclonal gammopathy of undetermined significanceFrancesca Prignano, Federica Ricceri, Leonardo Pescitelli, et al.
Current Pharmaceutical Biotechnology|June 12, 2020
Novel Therapeutic Approaches and Targets for the Treatment of Atopic DermatitisLeonardo Pescitelli, Elia Rosi, Federica Ricceri, et al.
Transplantation|October 18, 2022
Psoriasis Flare in a Liver Transplant Patient: A Case Report of a Successful Treatment With ApremilastElia Rosi, Maria Thais Fastame, Antonella Di Cesare, et al.
Journal of Cutaneous Pathology|March 27, 2007
Fibrosis in regressing melanoma versus nonfibrosis in halo nevus upon melanocyte disappearance: could it be related to a different cytokine microenvironment?Silvia Moretti, Adelina Spallanzani, Cinzia Pinzi, et al.
Pediatric Dermatology|February 13, 2016
A Pediatric Case of Sclerodermatous Graft-Versus-Host Disease Responsive to Ultraviolet A1 PhototherapyLinda Lazzeri, Lara Tripo, Leonardo Pescitelli, et al.
Expert Opinion on Biological Therapy|August 23, 2022
Targeting IL-17A for the treatment of pustular psoriasis: a comprehensive reviewElia Rosi, Maria Thais Fastame, Antonella Di Cesare, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|June 22, 2026
Concomitant HS and PsO: Disease severity and inflammatory phenotypes during biologic therapyElisabetta Magnaterra, Elia Rosi, Antonella Di Cesare, et al.
International Journal of Dermatology|November 2, 2011
Why is Kikuchi-Fujimoto disease misleading?Francesca Prignano, Angelo Massimiliano D'Erme, Fabio Zanieri, et al.
JAAD Case Reports|February 12, 2019
Comment on "Oral lichenoid reaction in a psoriatic patient treated with secukinumab: A drug-related rather than a class-related adverse event?"Antonella Di Cesare, Roberto Maglie, Leonardo Pescitelli, et al.
International Journal of Dermatology|January 20, 2018
Cutaneous hyperpigmentation induced by apremilastAntonella Di Cesare, Leonardo Pescitelli, Federica Ricceri, et al.
Pageof 20